Filtered By:
Specialty: General Medicine
Management: Hospitals
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1219 results found since Jan 2013.
Association between post-COVID-19 status and perioperative morbidity and mortality: protocol for an ambispective cohort study
This study aims to explore the association between time to surgery after COVID-19 diagnosis and the risk of postoperative morbidity and mortality.
Methods and analysis
This is a single-centre ambispective cohort study. Patients with preoperative SARS-CoV-2 infection who require inpatient surgical intervention from 1 December 2022 to 28 February 2023 will be included. Baseline assessment will include the time interval between preoperative SARS-CoV-2 infection and surgery, COVID-19 diagnosis and symptoms, vaccination status and routine preoperative evaluations. The primary outcome will be postoperative composite complicatio...
Source: BMJ Open - September 14, 2023 Category: General Medicine Authors: Che, L., Yu, J., Bai, X., Wang, Y., Zhang, Y., Xu, L., Shen, L., Huang, Y. Tags: Open access, Anaesthesia, COVID-19 Source Type: research
COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia
J Med Life. 2023 Jun;16(6):873-882. doi: 10.25122/jml-2023-0037.ABSTRACTThe severity of the 2019 coronavirus disease (COVID-19) and its effects remain unpredictable. Certain factors, such as obesity, hypertension, and type 2 diabetes mellitus, may increase the severity of the disease. Rheumatology experts suggest that patients with active autoimmune conditions and controlled autoimmune diseases on immunosuppressive therapy may be at higher risk of developing severe COVID-19. In this retrospective observational study, we aimed to examine the patterns of COVID-19 in patients with underlying rheumatological diseases and their...
Source: Journal of Medicine and Life - September 7, 2023 Category: General Medicine Authors: Safi Alqatari Ameera Nemer Manal Hasan Raed Bukhari Reem Al Argan Dania Al Khafaji Abrar Alwaheed Alaa Alzaki Marwan Al-Wazza Sara Al Warthan Abir Al Saeed Feda Albeladi Hashim Almeer Reem AlSulaiman Ahmed Abu Quren Source Type: research
Early 3 ‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study
Exp Ther Med. 2023 Aug 9;26(4):462. doi: 10.3892/etm.2023.12161. eCollection 2023 Oct.ABSTRACTRemdesivir, a viral RNA polymerase inhibitor, has constituted a key component of therapeutic regimens against the pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Originally approved for administration in hospitalized patients, remdesivir leads to improved outcomes in patients with moderate to severe coronavirus disease 2019 (COVID-19). After proving to be effective in hospitalized patients, its use gained approval in early-stage disease for symptomatic outpatients who are at a high risk of progress...
Source: Experimental and Therapeutic Medicine - September 4, 2023 Category: General Medicine Authors: Vasiliki Epameinondas Georgakopoulou Aikaterini Gkoufa Sotiria Makrodimitri Dimitrios Basoulis Aristeidis Tsakanikas Georgios Karamanakos Elpida Mastrogianni Pantazis M Voutsinas Demetrios A Spandidos Chrysovalantis V Papageorgiou Maria N Gamaletsou Nikol Source Type: research
